G

Genetic Signatures
GSS

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
A$82.91M
EV
A$43.13M
Shares Outstanding
227.17M
Beta
0.64

Wall Street View

Analyst Rating
BUY
Analyst Target Price
A$0.88
P/E 2025E
-
P/Revenue 2025E
5.13x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Genetic Signatures Limited

gainify

G

Genetic Signatures Limited

GSS

Genetic Signatures Limited operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas. The company offers enteric bacteria, Enteroaggregative E.coli aggR and aaiC, enteric viral, enteric protozoan, enteri...

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Rossiter, Allison

Employees

IPO Date

2015-03-30

Headquarters

Heart Research Institute, 7 Eliza Street, Newtown, New South Wales, 2042, Australia

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.